Taro Pharmaceutical EPS beats by $0.22, misses on revenue
Taro Pharmaceutical (NYSE:TARO): Q3 GAAP EPS of $1.76 beats by $0.22. Revenue of $147.68M (-8.2% Y|Y) misses by $24.33M. Press Release
Taro Pharmaceutical EPS beats by $0.22, misses on revenue
Taro Pharmaceutical (NYSE:TARO): Q3 GAAP EPS of $1.76 beats by $0.22. Revenue of $147.68M (-8.2% Y|Y) misses by $24.33M. Press Release